Haoxi Health Technology Ltd cash flow statement

In fiscal 2026, Haoxi Health Technology Ltd's operations generated −$2.6m of cash; it spent $0 on capital projects, leaving free cash flow of −$2.6m.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Haoxi Health Technology Ltd: cash flow statement, annual
Fiscal year	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	2026Jun 2026
Cash from operations	−675	−872	−748	−3,358	−2,568
Depreciation and amortisation	2	8	11	295	309
Stock-based pay	158	1,994	—	59	—
Capital spending	9	46	55	0	0
Free cash flow	−684	−918	−803	−3,358	−2,568
Free cash flow after stock pay	−842	−2,912	—	−3,417	—
Shares issued	164	1,994	8,975	—	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: CCEL vs HAO AMS vs HAO HAO vs RDGT

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Haoxi Health Technology Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Haoxi Health Technology Ltd.